Hepato-lenticular degeneration stands almost alone among diseases of the nervous system in the wealth of biochemical information available, but there is, as yet, no generally acceptable explanation of the underlying disorder of metabolism. Any such theory must take into account all the biochemical abnormalities so far discovered. The disease is an inborn error of metabolism transmitted by recessive inheritance (Beam, 1953) . Copper accumulates in the liver and brain (Cumings, 1948) and cornea (Brand and Takats, 1951) and, paradoxically, the urinary excretion of copper is greatly increased (Mandelbrote, Stanier, Thompson, and Thruston, 1948) . This excretion is more than offset by diminished elimination in the faeces, resulting in a strongly positive copper balance (Zimdahl, Hyman, and Cook, 1953) . The normal specific copper plasma protein, caeruloplasmin, is largely deficient (Scheinberg and Gitlin, 1952) . The results of treatment with dimercaprol (B.A.L.) reported by Denny-Brown and Porter (1951) leave little doubt that the neurological symptoms at least are due to copper poisoning. In addition to these abnormalities of copper metabolism the disease is characterized by renal amino-aciduria (Uzman and Denny-Brown, 1948) and by the presence of specific peptides in the urine (Uzman and Hood, 1952; Uzman, 1953) .
Opinion is divided as to whether the accumulation of copper in the body is of primary importance or is merely secondary to some other metabolic disorder which is itself responsible for the lesions in the liver and brain. It is therefore important to establish whether this accumulation is due to over-absorption of the metal or to undue retention in the tissues. Zimdahl and others (1953) claimed to have demonstrated over-absorption but their results could equally be explained by failure of the normal route of excretion into the intestine. Their method of copper balance on a varying copper intake does not permit distinction between faecal copper that has passed through unabsorbed and that which has been excreted into the intestine. To do this it is necessary to follow the fate of a single dose, which may be attempted either by giving a loading dose to a patient already established on a constant copper intake, a difficult task, or else, as suggested by Matthews, Milne, and Bell (1952) , by using radioactive copper, 64Cu.
There are numerous difficulties in such an investigation. The isotope can only be obtained as a small proportion of inactive carrier and has a short halflife of 12-8 hours. Other limiting factors are the potential toxicity of copper, the possible effects of radiation, and the small number of patients with this uncommon disease available for investigation.
Clinical Material
Two patients were investigated. Both were young adult males with the more chronic " pseudosclerotic" form of the disease, and showed the characteristic amino-aciduria and increased urinary copper 25 u.C was given to the two patients and to two controls. The general shape of the plasma curve was investigated and urine was collected as passed in the first few hours following ingestion, but the activity was not sufficient for elimination in the faeces to be followed for long enough with the apparatus available. In the second series 4 95 mg. of labelled copper with an approximate activity of 125 uLC was given to the two patients and to two different controls, together with a carmine marker. Plasma levels were estimated at times suggested by the results of the first experiment and 24-hour specimens of urine and faeces were collected.
Blood was heparinized and centrifuged and the activity of the plasma was counted directly in a liquid counter (M.R.C. type M6M). Urine was also counted directly. Specimens of faeces were thoroughly mixed and approximately 5 g. portions were digested by the method of Eden and Green (1940) Case 1 and in both controls but proved difficult in Case 2 in whom some degree of faecal retention could not be excluded. In view of the high plasma curve, severe disease, and high urinary excretion in this patient, and also the recovery of some radiocopper on the first day it is possible that the figure of less than 3 % recovery in four days may not be misleading and the result is included. In Case 1, 28-5% of the dose was recovered and in the controls 58-5 and 53-5%. The recovery of only small quantities on the fourth day shows that the greater part of the dose remaining unabsorbed had been recovered.
Urine.-A very striking difference in urinary excretion was found both in the 24-hour specimens (Fig. 3) Ravesteyn, 1944; Gubler, Lahey, Cartwright, and Wintrobe, 1953) . The doses of copper employed in the present investigation cannot be described as physiological in that such amounts would not normally be encountered in a single meal. They are, however, much more closely related to the normal minimum daily requirement of 2 mg. (Cartwright, 1950) than those used in previous investigations with unlabelled copper. Schubert and Riezler (1947) reported the only similar investigation in man using 64Cu, but did not follow plasma levels closely in the few hours after ingestion or report individual results in detail. It is difficult to compare their results with the present figures but levels appear to have been of the same order. The results reported here suggest that a rapid initial absorption takes place and that the newly absorbed copper reaches equilibrium with pre-existing plasma copper after about four hours.
The very small quantities recovered in the urine confirm that this method of excretion is of little importance in normal copper metabolism (van Ravesteyn, 1944) . Recovery of 58-5 and 53 5% of the dose in the faeces does not agree very well with the results of Schubert, Maurer, and Riezler (1948) who recovered 91% of 3 79 mg. of labelled copper in five days. The latter figure would imply that most of the normal faecal copper is derived directly from unabsorbed ingested copper. Zimdahl and others (1953) found that when copper absorption was largely prevented by means of an ion exchange resin the faecal copper was greatly in excess of the intake over a 12-day period, presumably due to the excretion of copper from body stores. In view of this large contribution of excreted copper to the total faecal copper the present figures appear reasonable. The quantity recovered undoubtedly contained a proportion of re-excreted copper but this could not be large for van Ravesteyn (1944) (1953) has recently advanced the theory that the initial metabolic disorder in hepato-lenticular degeneration is one of proteolytic activity leading to the accumulation in the tissues of the specific peptides that he has identified in the urine. The peptides readily combine with copper and would lead to a secondary accumulation of copper in the tissues. He has suggested that the peptides, either free or combined with copper, compete with aminoacids for reabsorption by the renal tubules, thus producing both amino-aciduria and the appearance of copper-peptide complexes in the urine. He has been able to show that most of the urinary copper in Wilson's disease is actually present as such complexes. On this theory the positive copper balance would presumably be due to undue retention of copper in the tissues and not to over-absorption.
An alternative theory is that the lack of some hypothetical regulating activity normally exerted by the copper plasma protein, caeruloplasmin, which is deficient in this disease, leads to chronic overabsorption of copper from the intestine. Hepatic and cerebral damage, abnormal peptide metabolism, and renal amino-aciduria would then all be attributable to copper poisoning. There is considerable evidence that the cerebral lesions are to a large extent reversible by treatment with B.A.L., and renal amino-aciduria has recently been shown to accompany lead poisoning (Wilson, Thomson, and Dent, 1953) . On either theory excessive excretion of copper in the urine might only be a late result of chronic accumulation in the body, and the discovery of amino-aciduria without excessive urinary copper in asymptomatic sibs of known cases of the disease (Uzman and Hood, 1952 ) cannot be used as an argument for the secondary nature of the disorder of copper metabolism.
The present investigation was designed to establish whether over-absorption of copper occurs in Wilson's disease or not. Unfortunately the small number of cases available did not allow conclusive results to be obtained. A considerably larger proportion of the ingested dose was, however, recovered from the faeces of the controls than of the patients and this finding is in favour of overabsorption, but requires confirmation in a larger series of patients.
No striking difference was found between plasma levels in the patients and in the controls, although rather higher levels were consistently found in the former. The plasma levels are the result of a number of variables including rate of absorption, rate of entry into the tissues, and rate of urinary excretion, and slight differences may therefore conceal considerable but opposing disturbances of these factors. The plasma levels therefore provide no evidence of over-absorption, but also do not suggest unduly rapid clearance of the plasma due to excessive uptake of copper by the tissues.
A very much larger proportion of the ingested dose was excreted in the urine by the patients than by the controls in spite of very similar plasma levels ( Figs. 1 and 3) . The problem of urinary excretion of copper was fully reviewed by Matthews and others (1952) A larger proportion of the ingested dose was recovered in the faeces of the controls than in the patients.
The patients passed a much larger proportion of the dose in the urine than did the controls. Plasma levels were not strikingly different in the patients and controls but slightly higher values were found in the former.
It is concluded that there was evidence of overabsorption of copper by the patients and that copper existed in an abnormal form in the plasma. 
